newsfilter
← Latest News
GlobeNewswire·

AGTC Appoints Abraham Scaria, Ph.D., as Chief Science Officer

With 25+ years of experience, Dr. Scaria has led numerous gene therapy programs from early research into clinical development Dr. Scaria completes a newly expanded management team in place to continue development of late-stage programs in XLRP and Ac